Kanis J A, Burlet N, Cooper C, Delmas P D, Reginster J-Y, Borgstrom F, Rizzoli R
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12.
Guidance is provided in a European setting on the assessment and treatment of postmenopausal women with or at risk from osteoporosis.
The European Foundation for Osteoporosis and Bone disease (subsequently the International Osteoporosis Foundation) published guidelines for the diagnosis and management of osteoporosis in 1997. This manuscript updates these in a European setting.
The following areas are reviewed: the role of bone mineral density measurement for the diagnosis of osteoporosis and assessment of fracture risk; general and pharmacological management of osteoporosis; monitoring of treatment; assessment of fracture risk; case finding strategies; investigation of patients; health economics of treatment.
A platform is provided on which specific guidelines can be developed for national use.
在欧洲背景下,针对患有骨质疏松症或有骨质疏松症风险的绝经后女性的评估与治疗提供了指导意见。
欧洲骨质疏松症与骨病基金会(后更名为国际骨质疏松症基金会)于1997年发布了骨质疏松症诊断与管理指南。本手稿在欧洲背景下对这些指南进行了更新。
对以下领域进行了综述:骨密度测量在骨质疏松症诊断和骨折风险评估中的作用;骨质疏松症的一般管理和药物治疗;治疗监测;骨折风险评估;病例发现策略;患者调查;治疗的卫生经济学。
提供了一个平台,可在此基础上制定供各国使用的具体指南。